Icon
+91 94997 68112
Login Register

SUNLENCA - (EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) ; Solution)

LENACAPAVIR SODIUM Gilead
EQ 463.5MG BASE/1.5ML (EQ 309MG BASE/ML) ; Solution
Less Than $1000 mn
None None
Less Than 5
 None
None None
SUNLENCA, a human immunodeficiency virus type 1 (HIV-1) capsid inhibitor, in combination with other antiretroviral(s), is indicated for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug resistant HIV-1 infection failing their current antiretroviral regimen due to resistance, intolerance, or safety considerations.
Yes
SUNLENCA Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
*** *********
*********** ********* *********** ********* *********** ********* ***** ***** ** ** *** ****** ********* ****** ********** *** *** ********* ** ***
  1. *** **, **** : * ****** **** ********* *** **** ***** ** ********* *** ****** **. *,***,*** (*** **, ****). **** **** ********* ** **** ****, ** **** ******** **** ** *** *** ****** ****** ***** ** *** **, ****.

SUNLENCA - (EQ 300MG BASE ; Tablet)

LENACAPAVIR SODIUM Gilead
EQ 300MG BASE ; Tablet
Less Than $1000 mn
None None
Less Than 5
 None
None None
SUNLENCA, a human immunodeficiency virus type 1 (HIV-1) capsid inhibitor, in combination with other antiretroviral(s), is indicated for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug resistant HIV-1 infection failing their current antiretroviral regimen due to resistance, intolerance, or safety considerations.
Yes
SUNLENCA Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
*** *********
*********** ********* *********** ********* *********** ********* ***** ***** ** ** *** ****** ********* ****** ********** *** *** ********* ** ***
  1. *** **, **** : * ****** **** ********* *** **** ***** ** ********* *** ****** **. *,***,*** (*** **, ****). **** **** ********* ** **** ****, ** **** ******** **** ** *** *** ****** ****** ***** ** *** **, ****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.